Gotowa bibliografia na temat „Helicobacter hepaticus”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Helicobacter hepaticus”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Helicobacter hepaticus"
Hynes, Sean O., Susann Teneberg, Niamh Roche i Torkel Wadström. "Glycoconjugate Binding of Gastric and Enterohepatic Helicobacter spp." Infection and Immunity 71, nr 5 (maj 2003): 2976–80. http://dx.doi.org/10.1128/iai.71.5.2976-2980.2003.
Pełny tekst źródłaBelzer, Clara, Jeroen Stoof, Catherine S. Beckwith, Ernst J. Kuipers, Johannes G. Kusters i Arnoud H. M. van Vliet. "Differential regulation of urease activity in Helicobacter hepaticus and Helicobacter pylori". Microbiology 151, nr 12 (1.12.2005): 3989–95. http://dx.doi.org/10.1099/mic.0.28188-0.
Pełny tekst źródłaKrishnan, Navasona, Alan R. Doster, Gerald E. Duhamel i Donald F. Becker. "Characterization of a Helicobacter hepaticus putA Mutant Strain in Host Colonization and Oxidative Stress". Infection and Immunity 76, nr 7 (5.05.2008): 3037–44. http://dx.doi.org/10.1128/iai.01737-07.
Pełny tekst źródłaYoung, Vincent B., Kimberly A. Knox i David B. Schauer. "Cytolethal Distending Toxin Sequence and Activity in the Enterohepatic Pathogen Helicobacter hepaticus". Infection and Immunity 68, nr 1 (1.01.2000): 184–91. http://dx.doi.org/10.1128/iai.68.1.184-191.2000.
Pełny tekst źródłaWhary, M. T., T. J. Morgan, C. A. Dangler, K. J. Gaudes, N. S. Taylor i J. G. Fox. "Chronic Active Hepatitis Induced by Helicobacter hepaticus in the A/JCr Mouse Is Associated with a Th1 Cell-Mediated Immune Response". Infection and Immunity 66, nr 7 (1.07.1998): 3142–48. http://dx.doi.org/10.1128/iai.66.7.3142-3148.1998.
Pełny tekst źródłaShen, Zeli, David B. Schauer, Harry L. T. Mobley i James G. Fox. "Development of a PCR-Restriction Fragment Length Polymorphism Assay Using the Nucleotide Sequence of the Helicobacter hepaticus Urease Structural Genes ureAB". Journal of Clinical Microbiology 36, nr 9 (1998): 2447–53. http://dx.doi.org/10.1128/jcm.36.9.2447-2453.1998.
Pełny tekst źródłaGarcía, Alexis, Melanie M. Ihrig, Rebecca C. Fry, Yan Feng, Sandy Xu, Samuel R. Boutin, Arlin B. Rogers, Suresh Muthupalani, Leona D. Samson i James G. Fox. "Genetic Susceptibility to Chronic Hepatitis Is Inherited Codominantly in Helicobacter hepaticus-Infected AB6F1 and B6AF1 Hybrid Male Mice, and Progression to Hepatocellular Carcinoma Is Linked to Hepatic Expression of Lipogenic Genes and Immune Function-Associated Networks". Infection and Immunity 76, nr 5 (19.02.2008): 1866–76. http://dx.doi.org/10.1128/iai.01044-07.
Pełny tekst źródłaPéré-Védrenne, Christelle, Wencan He, Lamia Azzi-Martin, Valérie Prouzet-Mauléon, Alice Buissonnière, Bruno Cardinaud, Philippe Lehours, Francis Mégraud, Christophe F. Grosset i Armelle Ménard. "The Nuclear Remodeling Induced by Helicobacter Cytolethal Distending Toxin Involves MAFB Oncoprotein". Toxins 12, nr 3 (12.03.2020): 174. http://dx.doi.org/10.3390/toxins12030174.
Pełny tekst źródłaAnanieva, Olga, Ingrid Nilsson, Tamara Vorobjova, Raivo Uibo i Torkel Wadström. "Immune Responses to Bile-Tolerant Helicobacter Species in Patients with Chronic Liver Diseases, a Randomized Population Group, and Healthy Blood Donors". Clinical and Vaccine Immunology 9, nr 6 (listopad 2002): 1160–64. http://dx.doi.org/10.1128/cdli.9.6.1160-1164.2002.
Pełny tekst źródłaLivingston, Robert S., Lela K. Riley, Reuel R. Hook, Cynthia L. Besch-Williford i Craig L. Franklin. "Cloning and Expression of an Immunogenic Membrane-Associated Protein of Helicobacter hepaticus for Use in an Enzyme-Linked Immunosorbent Assay". Clinical Diagnostic Laboratory Immunology 6, nr 5 (1.09.1999): 745–50. http://dx.doi.org/10.1128/cdli.6.5.745-750.1999.
Pełny tekst źródłaRozprawy doktorskie na temat "Helicobacter hepaticus"
Myles, Matthew Howard. "Helicobacter hepaticus induced gene dysregulation in mice /". Free to MU Campus, others may purchase, 2004. http://wwwlib.umi.com/cr/mo/fullcit?p3137733.
Pełny tekst źródłaLefevre, Marie. "Role of Helicobacter hepaticus in intestinal inflammation". Thesis, University of Oxford, 2008. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.504422.
Pełny tekst źródłaThomas, Theodore Seth. "Development of a capillary based helicobacter hepaticus biosensor". Diss., Columbia, Mo. : University of Missouri-Columbia, 2006. http://hdl.handle.net/10355/4572.
Pełny tekst źródłaThe entire dissertation/thesis text is included in the research.pdf file; the official abstract appears in the short.pdf file (which also appears in the research.pdf); a non-technical general description, or public abstract, appears in the public.pdf file. Title from title screen of research.pdf file viewed on (June 27, 2007) Includes bibliographical references.
McBee, Megan Earley. "Immunomodulation by subclinical persistent infection with Helicobacter hepaticus". Thesis, Massachusetts Institute of Technology, 2007. http://hdl.handle.net/1721.1/39916.
Pełny tekst źródłaIncludes bibliographical references (leaves 112-118).
Recognition of polymicrobial infections is becoming important for understanding differential host responses to environmental exposures, vaccines, as well as therapeutics. Citrobacter rodentium is a well-characterized model of infectious colitis with particular usefulness for modeling human diarrheal disease or inflammatory bowel disease. Infection with Helicobacter hepaticus is subclinical and persistent in C57BL/6 mice, but causes disease in susceptible strains and immunodeficient mice. To test the hypothesis that subclinical persistent infection modulates the host response to diarrheal disease a polymicrobial mouse model utilizing H. hepaticus and C. rodentium was developed and characterized. Concurrent infection has been shown to modulate disease outcome through several mechanisms including: cross-reactivity between viral antigens; shifting T cell response from Th1 to Th2 by helminth infection; and induction of regulatory T cells that suppress host response. In this new model of polymicrobial infection, a new paradigm in which persistent infection prolonged the course of acute colitis associated with a deviation from Thl-biased disease to Th17 was observed.
(cont.) In addition, Foxp3+naturally-occurring regulatory T cells (nTre,) were markedly increased during active colitis. The accumulation of nTreg was sustained when mice were persistently infected with H. hepaticus, indicating on-going active colitis. Although persistent infection was able to modulate host response, protective immunity to a subsequent C. rodentium infection was not compromised. Persistent infection also modulated host response to soluble antigen by preventing induction of oral tolerance to single bolus, but not to continuous, high-dose antigen feeding. Using H. hepaticus infection of C57BL/6 mice, models to investigate the immunomodulatory potential of persistent infection on immunogenic responses of protective immunity to enteric infection, host response to polymicrobial enteric infection, as well as tolerogenic responses to soluble antigen were developed. These models establish baselines for further investigation into the influences of persistent infection on host immune responses.
by Megan Earley McBee.
Ph.D.
Boutin, Samuel R. 1952. "Molecular pathogenesis of Helicobacter hepaticus induced liver disease". Thesis, Massachusetts Institute of Technology, 2005. http://hdl.handle.net/1721.1/35696.
Pełny tekst źródłaThis electronic version was submitted by the student author. The certified thesis is available in the Institute Archives and Special Collections.
Includes bibliographical references.
Helicobacter hepaticus infection of A/JCr mice is a model of liver cancer resulting from chronic active inflammation. We monitored hepatic global gene expression profiles and correlated them to histological liver lesions in H. hepaticus infected and control male A/JCr mice at 3 months, 6 months, and 1 year of age. We used an Affymetrix-based oligonucleotide microarray platform on the premise that a specific genetic expression signature at isolated time points would be indicative of disease status. Model based expression index comparisons generated by dChip yielded consistent profiles of differential gene expression for H. hepaticus infected male mice with progressive liver disease versus uninfected control mice within each age group. Linear discriminant analysis and principal component analysis allowed segregation of mice based on combined age and lesion status, or age alone. Up-regulated genes present throughout the 12 month study involved inflammation, tissue repair, and host immune function. Upregulation of putative tumor and proliferation markers correlated with advancing hepatocellular dysplasia. Transcriptionally down-regulated genes in mice with liver lesions included those related to peroxisome proliferator, cholesterol, and steroid metabolism pathways. Transcriptional profiling of hepatic genes documented gene expression signatures in the livers of H. hepaticus infected male A/JCr mice with chronic progressive hepatitis and preneoplastic liver lesions, complemented the histopathological diagnosis, and suggested molecular targets for the monitoring and intervention of disease progression prior to the onset of hepatocellular neoplasia. Our laboratory, in collaboration with Professors Suerbaum and Schauer, recently identified a
(cont.) 70kb genomic island in Helicobacter hepaticus strain ATCC 51488 as a putative pathogenicity island (HhPAI) (Suerbaum et al, PNAS, 2003). This region within H. hepaticus contains genes HH0233-HH0302, a differential GC content, several long tandem repeats but no flanking repeats, and three components of a type IV secretion system (T4SS). A/JCr mice were experimentally infected with three naturally occurring strains of H. hepaticus including the type strain H. hepaticus ATCC 51488 strain (Hh 3B1) isolated from A/JCr mice, MIT 96-1809 (Hh NET) isolated from mice shipped from the Netherlands, and MIT-96-284 (HhG) isolated from mice acquired from Germany.4 HhNET (missing most of the HhPAI) infected male A/JCR mice exhibited a significantly lower prevalence (p<.05) of hepatic lesions at 6 months post infection than Hh 3B1 with an intact HhPAI. Hh G also has a large segment of the genomic island deleted, but not as many genes are deleted as compared to Hh NET. Hh G also demonstrated a lower prevalence of hepatic lesions. This variable pathological effect was evident in male mice only. The severity of chronic active inflammation in the liver of the H. hepaticus infected A/JCr mice depended on H. hepaticus liver colonization levels. The in vivo results support the presence of the HhPAI as a legitimate virulence determinant and predictor of severity of liver lesions in H. hepaticus infected A/JCr male mice. To further determine the differences in virulence of the H. hepaticus strains Hh 3B1, Hh NET, Hh G and an isogenic mutant H. ...
by Samuel R. Boutin.
Ph.D.in Molecular and Systems Bacterial Pathogenesis
Avenaud, Philippe. "Hélicobacters et carcinomes hépatocelluaires : recherche de bactéries du genre Helicobacter dans le foie humain et de souris par méthode moléculaire". Bordeaux 2, 2003. http://www.theses.fr/2003BOR21067.
Pełny tekst źródłaBelzer, Clara. "Surviving the Enterohepatic Tract: Molecular Mechanisms of Stress Adaptation in Helicobacter hepaticus". [S.l.] : Rotterdam : [The Author] ; Erasmus University [Host], 2007. http://hdl.handle.net/1765/10647.
Pełny tekst źródłaOkoli, Arinze Stanley Medical Sciences Faculty of Medicine UNSW. "Molecular studies of the response of Helicobacter hepaticus to bile, and the effect of Helicobacter bilis on human hepatoma cells". Publisher:University of New South Wales. Medical Sciences, 2009. http://handle.unsw.edu.au/1959.4/43379.
Pełny tekst źródłaEvans, Stephanie. "A computational approach to studying the processes active during Helicobacter hepaticus-induced intestinal inflammation". Thesis, University of York, 2016. http://etheses.whiterose.ac.uk/16125/.
Pełny tekst źródłaKamdar, Shraddha Rashmi. "Profiling of microRNAs and IL-10 expression in intestinal CD4+ T cells following infection with Helicobacter hepaticus". Thesis, University of York, 2015. http://etheses.whiterose.ac.uk/12188/.
Pełny tekst źródłaKsiążki na temat "Helicobacter hepaticus"
Keshav, Satish, i Alexandra Kent. Gastrointestinal infections. Redaktorzy Patrick Davey i David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0197.
Pełny tekst źródłaBulterys, Marc, Julia Brotherton i Ding-Shinn Chen. Prevention of Infection-Related Cancers. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780190238667.003.0066.
Pełny tekst źródłaFranceschi, Silvia, Hashem B. El-Serag, David Forman, Robert Newton i Martyn Plummer. Infectious Agents. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780190238667.003.0024.
Pełny tekst źródłaCzęści książek na temat "Helicobacter hepaticus"
Fox, J. G. "Helicobacter hepaticus and Helicobacter bilis: proinflammatory modulators of enterohepatic disease". W Helicobactor pylori, 15–29. Dordrecht: Springer Netherlands, 2003. http://dx.doi.org/10.1007/978-94-017-1763-2_2.
Pełny tekst źródłaFox, J. G., K. A. Andrutis i J. Yu. "Animal models for Helicobacter-induced gastric and hepatic cancer". W Helicobacter pylori, 504–22. Dordrecht: Springer Netherlands, 1994. http://dx.doi.org/10.1007/978-94-011-1418-9_49.
Pełny tekst źródłaBurnens, André P., John Stanley i Jacques Nicolet. "Possible Association of Helicobacter pullorum with Lesions of Vibrionic Hepatitis in Poultry". W Campylobacters, Helicobacters, and Related Organisms, 291–93. Boston, MA: Springer US, 1996. http://dx.doi.org/10.1007/978-1-4757-9558-5_51.
Pełny tekst źródłaSimon, Chantal, Hazel Everitt, Françoise van Dorp, Nazia Hussain, Emma Nash i Danielle Peet. "Gastrointestinal medicine". W Oxford Handbook of General Practice, 343–406. Oxford University Press, 2020. http://dx.doi.org/10.1093/med/9780198808183.003.0012.
Pełny tekst źródłaStreszczenia konferencji na temat "Helicobacter hepaticus"
Gong, Guanyu, Sureshkumar Muthupalani, Gerald N. Wogan, James G. Fox i Steven R. Tannenbaum. "Abstract A17: Colitis-associated tumorigenesis in the Rag2 -/- Helicobacter hepaticus-infected mouse features DNA damage and Retinoblastoma-mediated cell proliferation via nitric oxide but not hypochlorous acid". W Abstracts: Third AACR International Conference on Frontiers in Basic Cancer Research - September 18-22, 2013; National Harbor, MD. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.fbcr13-a17.
Pełny tekst źródła